These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38882835)

  • 21. The crisis in access to essential medicines in India: key issues which call for action.
    Bhargava A; Kalantri SP
    Indian J Med Ethics; 2013; 10(2):86-95. PubMed ID: 23697486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Availability of Key Essential Medicines in Public Health Facilities of South Indian Union Territory: One of the Crucial Components of Universal Health Coverage.
    Meena DK; Jayanthi M; Ramasamy K; T M
    Cureus; 2021 Nov; 13(11):e19419. PubMed ID: 34926013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to cardiovascular medicines in low- and middle-income countries: a mini review.
    Harrison MA; Marfo AFA; Annan A; Ankrah DNA
    Glob Health Res Policy; 2023 May; 8(1):17. PubMed ID: 37221559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Availability of essential medicines during the COVID-19 pandemic: A qualitative study examining experiences and level of preparedness in Kenya.
    Onyango JO; Ogira D; Kokwaro G
    PLOS Glob Public Health; 2024; 4(7):e0002547. PubMed ID: 39074106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health supply chain system in Uganda: assessment of status and of performance of health facilities.
    Lugada E; Ochola I; Kirunda A; Sembatya M; Mwebaze S; Olowo M; Ladwar DO; Komakech H
    J Pharm Policy Pract; 2022 Oct; 15(1):58. PubMed ID: 36199111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicines and vaccines supply chains challenges in Nigeria: a scoping review.
    Olutuase VO; Iwu-Jaja CJ; Akuoko CP; Adewuyi EO; Khanal V
    BMC Public Health; 2022 Jan; 22(1):11. PubMed ID: 34986820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.
    Sharma A; Kaplan WA; Satheesh G; Poudyal IP; Gyawali P; Neupane D; Bhandari PM; Malla M; Sapkota S; Mishra SR
    Glob Heart; 2021 May; 16(1):38. PubMed ID: 34040951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of access to childhood cancer medicines: a comparative, mixed-methods analysis of four Caribbean countries.
    Boateng R; Petricca K; Tang B; Parikh S; SinQuee-Brown C; Alexis C; Browne-Farmer C; Reece-Mills M; Salmon SM; Bodkyn C; Gupta S; Maguire B; Denburg AE
    Lancet Glob Health; 2021 Sep; 9(9):e1314-e1324. PubMed ID: 34416215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology.
    Sisay M; Amare F; Hagos B; Edessa D
    J Pharm Policy Pract; 2021 Jul; 14(1):57. PubMed ID: 34225781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
    Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S;
    Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India.
    Katageri G; Charantimath U; Joshi A; Vidler M; Ramadurg U; Sharma S; Bannale S; Payne BA; Rakaraddi S; Karadiguddi C; Mungarwadi G; Kavi A; Sawchuck D; Derman R; Goudar S; Mallapur A; Bellad M; Magee LA; Qureshi R; von Dadelszen P;
    Reprod Health; 2018 Jun; 15(Suppl 1):91. PubMed ID: 29945665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of procurement, distribution, availability, and utilization of rabies biologicals for postexposure prophylaxis in seven states of India.
    D Hanumanthaiah AN; Haradanhalli RS
    Indian J Public Health; 2019 Sep; 63(Supplement):S31-S36. PubMed ID: 31603089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public health supply chain for iron and folic acid supplementation in India: Status, bottlenecks and an agenda for corrective action under Anemia Mukt Bharat strategy.
    Ahmad K; Singh J; Singh RA; Saxena A; Varghese M; Ghosh S; Roy S; Yadav K; Joe W; Patel N
    PLoS One; 2023; 18(2):e0279827. PubMed ID: 36827429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.
    Muir D; Orlando C; Newton B
    Campbell Syst Rev; 2024 Jun; 20(2):e1406. PubMed ID: 38873396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS).
    Krishnan A; Mathur P; Kulothungan V; Salve HR; Leburu S; Amarchand R; Nongkynrih B; Chaturvedi HK; Ganeshkumar P; K S VU; Laxmaiah A; Boruah M; Kumar S; Patro BK; Raghav PR; Rajkumar P; Sarma PS; Sharma R; Tambe M; Arlappa N; Mahanta TG; Bhuyan PJ; Joshi RP; Pakhare AP; Galhotra A; Kumar D; Behera BK; Topno RK; Gupta MK; Rustagi N; Trivedi AV; Thankappan KR; Gupta S; Garg S; Shelke SC; ; ;
    BMC Health Serv Res; 2021 Jul; 21(1):757. PubMed ID: 34332569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buffer Stock Inventory Control Mechanism: An Approach of Minimizing the Buffer Stock Level Through Segmentation at a Tertiary Care Rural Hospital.
    Guru RR; Mitra S; Jadhav SJ; Maikano AK; Kumar R
    Cureus; 2024 Aug; 16(8):e67423. PubMed ID: 39310474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to accessing internationally controlled essential medicines in sub-saharan Africa: A scoping review.
    Ooms GI; van Oirschot J; de Kant D; van den Ham HA; Mantel-Teeuwisse AK; Reed T
    Int J Drug Policy; 2023 Aug; 118():104078. PubMed ID: 37276779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with the availability and affordability of essential cardiovascular disease medicines in low- and middle-income countries: A systematic review.
    Lotfizadeh A; Palafox B; Takallou A; Balabanova D; McKee M; Murphy A
    PLOS Glob Public Health; 2022; 2(3):e0000072. PubMed ID: 36962256
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.